Panhypopituitarism: Genetic versus acquired etiological factors

Journal of Pediatric Endocrinology and Metabolism

Volumn 20, Issue 1, 2007, Pages 27-36

  Coya, R ^a   Vela, A ^a   Perez de Nanclares G ^a   Rica, I ^a   Castano L ^a   Busturia, M A ^a   Martul, Pedro ^a   Albisu, J ^b   Aleixandre, F ^c   Barrio, R ^d   Bell, J ^e   Cortazar, A ^a   Diaz Cadorniga F ^f   Fernandez C ^g   Ferragut, J ^h   Luzuriaga, C ⁱ   Oyarzabal, M ^j   Riano I ^k   Rodriguez A ^l   Rodriguez M ^m   Ruiz Cano, J ⁿ   Santos, L ^o   Sobradillo, B ^g   Villabona, C ^p   Zapico, M ^q   more..

^a HOSPITAL DE CRUCES   (Spain)

^b HOSPITAL DONOSTIA   (Spain)

^c Elda Hospital   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

^e HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^f Hospital Asturias   (Spain)

^g HOSPITAL DE BASURTO   (Spain)

^h HOSPITAL SON DURETA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^j Universidad Pública de Navarra   (Spain)

^k Hospital Cangas de Narcea   (Spain)

^l HOSPITAL TXAGORRITXU   (Spain)

^m HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

ⁿ Hospital of Albacete   (Spain)

^o HOSPITAL MARINA ALTA   (Spain)

^p HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^q HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

more..

Author keywords

Combined pituitary hormone deficiency; HESX1; Human; POUF1; PROP1

Indexed keywords

CORTICOTROPIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HESX1; TRANSCRIPTION FACTOR PIT 1; TRANSCRIPTION FACTOR POUF1; TRANSCRIPTION FACTOR PROP1; UNCLASSIFIED DRUG; HESX1 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; HYPOPHYSIS HORMONE; POU1F1 PROTEIN, HUMAN; PROPHET OF PIT 1 PROTEIN; PROPHET OF PIT-1 PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BREECH EXTRACTION; CHILD; CLINICAL ARTICLE; ENDOCRINE FUNCTION TEST; ENVIRONMENTAL FACTOR; EXON; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENETIC ANALYSIS; GROWTH HORMONE BLOOD LEVEL; HORMONE DEFICIENCY; HUMAN; HYPOPITUITARISM; INTRON; MALE; MISSENSE MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN POLYMORPHISM; SEPTOOPTIC DYSPLASIA; SEX DIFFERENCE; AMINO ACID SEQUENCE; ANIMAL; GENETIC POLYMORPHISM; GENETICS; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHENOTYPE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; HYPOPITUITARISM; MALE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PHENOTYPE; PITUITARY HORMONES; POLYMORPHISM, GENETIC; SEPTO-OPTIC DYSPLASIA; TRANSCRIPTION FACTOR PIT-1;

EID: 34047250990     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2007.20.1.27     Document Type: Article

References (24)

1. Cushman LJ, Showalter AD, Rhodes SJ. Genetic defects in the development and function of the anterior pituitary gland. Ann Med 2002; 34: 179-191.
2. Reynaud R, Saveanu A, Barlie A, Enjalbert A, Brue T. Pituitary hormone deficiencies due to transcription factor gene alterations. Growth Horm IGF Res 2004; 14: 442-448.
3. Cohen LE, Radovick S. Molecular basis of combined pituitary hormone deficiencies. Endocr Rev 2002; 23: 431-442.
4. Parks JS, Brown MR, Hurley DL, Phelp CJ, Wajnrajch MP. Heritable disorders of pituitary development. J Clin Endocrinol Metab 1999; 84: 4362-4370.
5. Rainbow LA, Rees SA, Shaikh MG, Shaw N, Colet T, Barrett TG, Kirk JMW. Mutation analysis of POUF1, PROP1 and HESX-1 show low frequency of mutations in children with sporadic forms of combined pituitary hormone deficiency and septo-optic dysplasia. Clin Endocrinol (Oxf) 2005; 62: 163-168.
6. Vallette-Kasic S, Barlier A, Teinturier C, Diaz A, Manavela M, Berthezène F, Bouchard P, Chaussain JL, Brauner R, Pellegrini-Bouiller I, Jaquet P, Enjalbert A, Brue T. PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. J Clin Endocrinol Metab 2001; 86: 4529-4535.
7. Lebl J, Vosahlo J, Pfaeffle RW, Stobbe H, Cerna J, Novotna D, Zapletalova J, Kalvachova B, Hana V, Weiss V, Blum WF. Auxological and endocrine phenotype in a population-based cohort of patients with PROP1 gene defects. Eur J Endocrinol 2005; 153: 389-396.
8. Mody S, Brownm MR, Parks JS. The spectrum of hypopituitarism caused by PROP1 mutations. Best Pract Res Clin Endocrinol Metab 2002; 16: 421-431.
9. Dattani MT. Growth hormone deficiency and combined pituitary hormone deficiency: does the genotype matter? Clin Endocrinol 2005; 63: 121-130.
10. Dattani MT, Martinez-Barbera JP, Thomas PQ, Brickman JM, Gupta R, Martensson IL, Toresson H, Fox M, Wales JKH, Hindmarsh PC, Kraus S, Beddington RSP, Robinson I. Mutations in the homeo-box gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 1998; 19: 125-133.
11. Kim SS, Kim Y. Clinical characteristics and molecular analysis of PIT1, PROP1, LHX3, and HESX1 in combined pituitary hormone deficiency patients with abnormal pituitary MR imaging. Horm Res 2003; 60: 277-283.
12. Del Rincon JP, Lerman I, Vazquez-Lamadrid J, Gomez-Perez FJ, Morales JJ, Mutchinick O. Hypopituitarism in two brothers born by breech delivery. Endocr Pract 1999; 5: 143-147.
13. Maghnie M, Larizza D, Triulzi D, Sampaolo P, Scotti G, Severi F. Hypopituitarism and stalk agenesis: a congenital syndrome worsened by breech delivery. Horm Res 1991; 35: 104-108.
14. Brodsky MC. Optic nerve hypoplasia with posterior pituitary ectopia: male predominance and nonassociation with breech delivery. Am J Ophthalmol 1999; 127: 238-239.
15. Osorio MGF, Kopp P, Marui S, Latronico AC, Mendonca BB, Arnhold IJP. Combined pituitary hormone deficiency caused by a novel mutation of a highly conserved residue (F88S) in the homeodomain of PROP-1. J Clin Endocrinol Metab 2000; 85: 2779-2785.
16. Blizzard RM, Johanson A. Disorders of growth. In: Kappy MS, Blizzard RM, Migeon CJ, eds. Wilkins: The Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence. Springfield, IL: CC Thomas, 1994; 383-455.
17. Cameron FJ, Khadilkar VV, Stanhope R. Pituitary dysfunction, morbidity and mortality with congenital midline malformation of the cerebrum. Eur J Pediatr 1999; 158: 97-102.
18. Pellini C, diNatale B, De Angelis R, Bressani N, Scotti G, Triulzi F, Chiumello G. Growth hormone deficiency in children: role of magnetic resonance imaging in assessing aetiopathogenesis and prognosis in idiopathic hypopituitarism. Eur J Pediatr 1990; 149: 536-541.
19. Thomas PQ, Dattani MT, Brickman JM, McNay D, Warne G, Zacharin M, Cameron F, Hurst J, Woods K, Dunger D, Stanhope R, Forrest S, Robinson I, Beddington RSP. Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. Hum Mol Genet 2001; 10: 39-45.
20. Cohen RN, Cohen LE, Botero D, Yu C, Sagar A, Jurkiewicz M, Radovick S. Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia. J Clin Endocrinol Metab 2003; 88: 4832-4839.
21. Tajima T, Hattorri T, Nakajima T, Okuhara K, Sato K, Abe S, Nakae J, Fujieda K. Sporadic heterozygous frameshift mutation of HESX1 causing pituitary and optic nerve hypoplasia and combined pituitary hormone deficiency in a Japanese patient. J Clin Endocrinol Metab 2003; 88: 45-50.
22. Roessmann U, Velasco ME, Small EJ, Hori A. Neuropathology of "septo-optic dyspalsia" (de Morsier syndrome) with immunohistochemical studies to the hypothalamus and pituitary gland. J Neuropathol Exp Neurol 1987; 64: 597-608.
23. Zaias B, Becker D. Septo-optic dysplasia: development of acquired abnormality? A case report. Trans Am Neurol Assoc 1978; 103: 273-277.
24. Melchor JC. Epidemiología de la presentación podálica. In: Fabre E, ed. Manual del Parto y Puerperio Patológicos. Zaragoza: Ino Reproducciones S.A., 1999; 155-164.